Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001829126-25-002362
Filing Date
2025-04-03
Accepted
2025-04-03 16:05:13
Documents
2
Period of Report
2025-04-03

Document Format Files

Seq Description Document Type Size
1 DEF 14C cyclacel_def14c.htm DEF 14C 119941
2 GRAPHIC img_001.jpg GRAPHIC 19400
  Complete submission text file 0001829126-25-002362.txt   147969
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 000-50626 | Film No.: 25809346
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)